Lantheus Holdings, Inc. (LNTH) Financial Ratios
14 years of historical data (2012–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
↓
16.81
↓-13% vs avg
5yr avg: 19.39
30Y Low6.6·High44.8
P/FCF
↓
19.10
-7% vs avg
5yr avg: 20.61
30Y Low6.6·High186.2
P/B Ratio
↓
6.52
+18% vs avg
5yr avg: 5.53
30Y Low1.4·High34.1
ROE
↑
21.4%
↓+10% vs avg
5yr avg: 19.5%
30Y Low-15%·High86%
Debt/EBITDA
↓
0.00
↓-100% vs avg
5yr avg: 2.39
30Y Low0.0·High15.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
LNTH Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Lantheus Holdings, Inc. trades at 30.5x earnings, 33% below its 5-year average of 45.2x, sitting at the 88th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 38%. On a free-cash-flow basis, the stock trades at 19.1x P/FCF, 7% below the 5-year average of 20.6x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $6.8B | $4.6B | $6.4B | $4.4B | $3.6B | $1.9B | $730M | $823M | $618M | $795M | $281M |
| Enterprise Value | $6.4B | $4.2B | $6.1B | $4.3B | $3.8B | $2.0B | $887M | $924M | $771M | $987M | $508M |
| P/E Ratio → | 30.46 | 19.52 | 20.52 | 13.33 | 127.40 | — | — | 25.96 | 15.19 | 6.45 | 10.49 |
| P/S Ratio | 4.39 | 2.95 | 4.18 | 3.36 | 3.85 | 4.59 | 2.15 | 2.37 | 1.80 | 2.40 | 0.93 |
| P/B Ratio | 6.52 | 4.18 | 5.89 | 5.34 | 8.05 | 4.20 | 1.42 | 7.18 | 8.71 | 34.15 | — |
| P/FCF | 19.10 | 12.87 | 13.00 | 16.83 | 13.67 | 46.67 | 186.20 | 14.11 | 15.06 | 21.36 | 6.65 |
| P/OCF | 17.33 | 11.67 | 11.77 | 14.27 | 12.78 | 36.16 | 44.54 | 10.23 | 10.10 | 14.52 | 5.66 |
P/E links to full P/E history page with 30-year chart
LNTH EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Lantheus Holdings, Inc.'s enterprise value stands at 16.8x EBITDA, 13% below its 5-year average of 19.4x. The Healthcare sector median is 14.2x, placing the stock at a 18% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.72 | 3.99 | 3.28 | 4.03 | 4.80 | 2.61 | 2.66 | 2.25 | 2.98 | 1.68 |
| EV / EBITDA | 16.81 | 11.02 | 11.73 | 10.03 | 44.81 | — | 43.27 | 14.21 | 9.84 | 13.91 | 6.78 |
| EV / EBIT | 20.60 | 12.58 | 13.57 | 9.88 | 111.17 | — | — | 21.88 | 11.52 | 17.01 | 9.25 |
| EV / FCF | — | 11.85 | 12.40 | 16.46 | 14.31 | 48.89 | 226.05 | 15.85 | 18.78 | 26.51 | 12.02 |
LNTH Profitability
Margins and return-on-capital ratios measuring operating efficiency
Lantheus Holdings, Inc. earns an operating margin of 20.2%. Operating margins have compressed from 28.1% to 20.2% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 21.4% indicates solid capital efficiency. ROIC of 30.6% represents excellent returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.1% | 61.1% | 64.4% | 54.7% | 62.2% | 44.1% | 40.9% | 50.3% | 50.9% | 48.9% | 45.6% |
| Operating Margin | 20.2% | 20.2% | 29.8% | 28.1% | 3.9% | -14.3% | -1.2% | 14.9% | 18.8% | 15.6% | 18.7% |
| Net Profit Margin | 15.2% | 15.2% | 20.4% | 25.2% | 3.0% | -16.8% | -4.0% | 9.1% | 11.8% | 37.2% | 8.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.4% | 21.4% | 32.8% | 51.7% | 6.2% | -14.6% | -4.3% | 34.1% | 85.9% | 529.8% | — |
| ROA | 11.1% | 11.1% | 17.2% | 22.0% | 2.6% | -8.2% | -2.1% | 7.5% | 9.8% | 38.6% | 10.7% |
| ROIC | 30.6% | 30.6% | 45.3% | 41.0% | 4.6% | -7.4% | -0.7% | 17.6% | 22.0% | 23.2% | 32.6% |
| ROCE | 17.1% | 17.1% | 28.5% | 28.7% | 3.9% | -7.8% | -0.7% | 14.2% | 17.8% | 18.9% | 27.0% |
LNTH Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Lantheus Holdings, Inc. carries a Debt/EBITDA ratio of 0.0x, which is very conservative (100% below the sector average of 3.2x). The company holds a net cash position — cash of $359M exceeds total debt of $738000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 16.9x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.57 | 0.76 | 1.30 | 0.41 | 0.46 | 1.70 | 3.75 | 11.51 | — |
| Debt / EBITDA | 0.00 | 0.00 | 1.19 | 1.45 | 6.94 | — | 11.51 | 2.99 | 3.40 | 3.78 | 3.72 |
| Net Debt / Equity | — | -0.33 | -0.27 | -0.12 | 0.38 | 0.20 | 0.30 | 0.89 | 2.16 | 8.24 | — |
| Net Debt / EBITDA | -0.94 | -0.94 | -0.56 | -0.23 | 2.00 | — | 7.63 | 1.56 | 1.95 | 2.70 | 3.03 |
| Debt / FCF | — | -1.01 | -0.59 | -0.37 | 0.64 | 2.22 | 39.85 | 1.74 | 3.73 | 5.15 | 5.37 |
| Interest Coverage | 16.89 | 16.89 | 22.91 | 21.53 | 4.72 | -8.68 | -0.21 | 3.10 | 3.85 | 3.15 | 2.06 |
Net cash position: cash ($359M) exceeds total debt ($738000)
LNTH Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Lantheus Holdings, Inc.'s current ratio of 2.70x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 5.80x to 2.70x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.70 | 2.70 | 5.52 | 5.80 | 2.74 | 2.61 | 2.29 | 2.62 | 3.70 | 3.16 | 2.53 |
| Quick Ratio | 2.51 | 2.51 | 5.23 | 5.45 | 2.59 | 2.22 | 1.84 | 2.17 | 3.08 | 2.60 | 2.13 |
| Cash Ratio | 1.08 | 1.08 | 3.80 | 3.81 | 1.68 | 1.09 | 0.99 | 1.41 | 2.15 | 1.63 | 1.17 |
| Asset Turnover | — | 0.69 | 0.77 | 0.79 | 0.71 | 0.49 | 0.39 | 0.86 | 0.78 | 0.86 | 1.18 |
| Inventory Turnover | 9.27 | 9.27 | 8.02 | 9.17 | 9.96 | 6.76 | 5.61 | 5.91 | 5.10 | 6.49 | 9.30 |
| Days Sales Outstanding | — | 84.91 | 76.44 | 80.04 | 83.30 | 76.69 | 58.07 | 45.74 | 46.51 | 44.34 | 44.52 |
LNTH Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Lantheus Holdings, Inc. returns 4.4% to shareholders annually primarily through share buybacks. The earnings yield of 3.3% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 3.3% | 5.1% | 4.9% | 7.5% | 0.8% | — | — | 3.9% | 6.6% | 15.5% | 9.5% |
| FCF Yield | 5.2% | 7.8% | 7.7% | 5.9% | 7.3% | 2.1% | 0.5% | 7.1% | 6.6% | 4.7% | 15.0% |
| Buyback Yield | 4.4% | 6.6% | 1.6% | 0.0% | 2.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 4.4% | 6.6% | 1.6% | 0.0% | 2.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $68M | $72M | $70M | $71M | $67M | $54M | $40M | $40M | $39M | $33M |
Peer Comparison
Compare LNTH with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 LNTHYou | $7B | 30.5 | 16.8 | 19.1 | 61.1% | 20.2% | 21.4% | 30.6% | 0.0 |
 RMD | $27B | 19.8 | 14.1 | 16.5 | 59.4% | 32.7% | 25.9% | 22.8% | 0.4 |
 BWXT | $19B | 57.2 | 47.0 | 63.7 | 22.9% | 10.1% | 28.5% | 10.1% | 4.7 |
 EXAS | $20B | -95.4 | — | 56.1 | 69.7% | -6.4% | -8.7% | -3.6% | — |
 ROIV | $23B | -73.1 | — | — | 84.4% | -15560.6% | -5.7% | -29.4% | — |
 GE | $374B | 43.8 | 38.2 | 51.4 | 36.8% | 19.1% | 45.3% | 24.7% | 2.1 |
 GEHC | $28B | 13.5 | 10.0 | 18.6 | 40.0% | 13.4% | 21.6% | 13.3% | 3.0 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 ISRG | $144B | 51.7 | 39.0 | 58.0 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
 NVST | $4B | 92.5 | 13.8 | 18.3 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 |
 PODD | $10B | 41.9 | 18.0 | 27.1 | 71.6% | 17.5% | 18.1% | 20.1% | 1.8 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 14 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
LNTH — Frequently Asked Questions
Quick answers to the most common questions about buying LNTH stock.
What is Lantheus Holdings, Inc.'s P/E ratio?
Lantheus Holdings, Inc.'s current P/E ratio is 30.5x. The historical average is 29.9x. This places it at the 88th percentile of its historical range.
What is Lantheus Holdings, Inc.'s EV/EBITDA?
Lantheus Holdings, Inc.'s current EV/EBITDA is 16.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.2x.
What is Lantheus Holdings, Inc.'s ROE?
Lantheus Holdings, Inc.'s return on equity (ROE) is 21.4%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 26.7%.
Is LNTH stock overvalued?
Based on historical data, Lantheus Holdings, Inc. is trading at a P/E of 30.5x. This is at the 88th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Lantheus Holdings, Inc.'s profit margins?
Lantheus Holdings, Inc. has 61.1% gross margin and 20.2% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does Lantheus Holdings, Inc. have?
Lantheus Holdings, Inc.'s Debt/EBITDA ratio is 0.0x, indicating low leverage. A ratio below 2x is generally considered financially healthy.